- Home
- TXG vs PACS Comparison
TXG vs PACS Comparison
Compare TXG & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TXG | PACS |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 7.6B |
| IPO Year | 2019 | 2024 |
Fundamental Metrics
Financial Performance| Metric | TXG | PACS |
|---|---|---|
| Price | $81.69 | $49.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 6 |
| Target Price | ★ $77.50 | $59.00 |
| AVG Volume (30 Days) | ★ 3.7M | 781.8K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 76.97 | ★ 221.05 |
| EPS | N/A | ★ 0.97 |
| Revenue | $245,893,000.00 | ★ $5,288,932,000.00 |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | $10.11 | $11.85 |
| P/E Ratio | ★ N/A | $50.65 |
| Revenue Growth | ★ 68.06 | 29.32 |
| 52 Week Low | $12.44 | $10.31 |
| 52 Week High | $102.81 | $50.38 |
Technical Indicators
Market Signals| Indicator | TXG | PACS |
|---|---|---|
| Relative Strength Index (RSI) | 56.91 | 67.23 |
| Support Level | $74.60 | $42.61 |
| Resistance Level | $102.81 | N/A |
| Average True Range (ATR) | 6.01 | 1.80 |
| MACD | 0.47 | 0.37 |
| Stochastic Oscillator | 70.45 | 90.74 |
Price Performance
Historical ComparisonAbout TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About PACS PACS Group Inc.
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.